Influence of Adjuvant Systemic Regimens on Contralateral Breast Cancer Risk and Receptor Subtype
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the National Cancer Institute
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Influence of Adjuvant Systemic Regimens on Contralateral Breast Cancer Risk and Receptor Subtype
J. Natl. Cancer Inst 2019 Jan 30;[EPub Ahead of Print], I Kramer, M Schaapveld, HSA Oldenburg, GS Sonke, D McCool, FE van Leeuwen, KK Van de Vijver, NS Russell, SC Linn, S Siesling, CW Menke-van der Houven van Oordt, MK SchmidtFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.